Long-term use of sedative hypnotics in older patients with insomnia
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Sleep Medicine
- Vol. 6 (2) , 107-113
- https://doi.org/10.1016/j.sleep.2004.10.015
Abstract
No abstract availableKeywords
Funding Information
- Veterans Affairs San Diego Healthcare System
This publication has 12 references indexed in Scilit:
- Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic InsomniaSleep, 2003
- Sleep disorders in the elderlyCurrent Treatment Options in Neurology, 2001
- Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomniaClinical Therapeutics, 2000
- Comparison of the Effects of Zaleplon, Zolpidem, and Triazolam on Memory, Learning, and Psychomotor PerformanceJournal of Clinical Psychopharmacology, 2000
- Zaleplon improves sleep without producing rebound effects in outpatients with insomniaInternational Clinical Psychopharmacology, 2000
- A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomniaSleep Medicine, 2000
- Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine HypnoticThe Journal of Clinical Psychiatry, 1999
- Insomnia, Health-Related Quality of Life and Healthcare Resource ConsumptionPharmacoEconomics, 1998
- Insomnia and Its TreatmentArchives of General Psychiatry, 1985
- “White Paper” on Sleep and AgingJournal of the American Geriatrics Society, 1982